MPM joins the his­toric SPAC boom as its blank check com­pa­ny files for an IPO

An­oth­er blank check com­pa­ny has filed to ride the biotech IPO wave, which shows no sign of crash­ing any­time soon.

Turmer­ic Ac­qui­si­tion, a spe­cial pur­pose ac­qui­si­tion com­pa­ny formed by Boston-based MPM Cap­i­tal, an­nounced on Mon­day that it’s look­ing for a $100 mil­lion raise. It will be one of sev­er­al to hit Nas­daq in a his­toric year for SPACs. It’s not clear which biotechs are in Tumer­ic’s sights — but it says it’s go­ing af­ter in­no­v­a­tive com­pa­nies with “new modal­i­ties”.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.